The synthesis of carbon linked bis-benzylisoquinolines using Mizoroki–Heck and Sonagashira coupling reactions by Batenburg-Nguyen, Uta et al.
University of Wollongong 
Research Online 
Faculty of Science - Papers (Archive) Faculty of Science, Medicine and Health 
2009 
The synthesis of carbon linked bis-benzylisoquinolines using 
Mizoroki–Heck and Sonagashira coupling reactions 
Uta Batenburg-Nguyen 
University of Wollongong, tam@uow.edu.au 
Alison T. Ung 
University of Wollongong 
Stephen G. Pyne 
University of Wollongong, spyne@uow.edu.au 
Follow this and additional works at: https://ro.uow.edu.au/scipapers 
 Part of the Life Sciences Commons, Physical Sciences and Mathematics Commons, and the Social 
and Behavioral Sciences Commons 
Recommended Citation 
Batenburg-Nguyen, Uta; Ung, Alison T.; and Pyne, Stephen G.: The synthesis of carbon linked bis-
benzylisoquinolines using Mizoroki–Heck and Sonagashira coupling reactions 2009. 
https://ro.uow.edu.au/scipapers/4581 
Research Online is the open access institutional repository for the University of Wollongong. For further information 
contact the UOW Library: research-pubs@uow.edu.au 
The synthesis of carbon linked bis-benzylisoquinolines using Mizoroki–Heck and 
Sonagashira coupling reactions 
Abstract 
Novel laudanosine dimers in which two laudanosine units are linked at C-2′ via a two or three-carbon 
linker (alkane, alkene or alkyne) have been prepared using palladium-catalysed cross-coupling reactions 
(Mizoroki–Heck and Sonagashira reactions). In one example, a second three-carbon linker between the 
two isoquinoline N-atoms was also present leading to a novel macrocyclic ring system. 
Keywords 
CMMB 
Disciplines 
Life Sciences | Physical Sciences and Mathematics | Social and Behavioral Sciences 
Publication Details 
Batenburg-Nguyen, U. T., Ung, A. T. & Pyne, S. G. (2009). The synthesis of carbon linked bis-
benzylisoquinolines using Mizoroki-Heck and Sonagashira coupling reactions. Tetrahedron, 65 (1), 
318-327. 
This journal article is available at Research Online: https://ro.uow.edu.au/scipapers/4581 
1 
The synthesis of carbon linked bis-benzylisoquinolines using Mizoroki-Heck and 
Sonagashira coupling reactions 
 
Uta Batenburg-Nguyen, Alison T. Ung* and Stephen G. Pyne* 
School of Chemistry, University of Wollongong, Wollongong, NSW, 2522, Australia 
 
Abstract: Novel laudanosine dimers in which two laudanosine units are linked at C-2’ via a two or 
three-carbon linker (alkane, alkene or alkyne) have been prepared using palladium-catalysed cross-
coupling reactions (Mizoroki-Heck and Sonagashira reactions). In one example, a second three-carbon 
linker between the two isoquinoline N-atoms was also present leading to a novel macrocyclic ring 
system. 
 
1. Introduction   
Over two hundred bisbenzylisoquinoline alkaloids are known, the majority of these have one or two 
ether linkages between the two benzylisoquinoline moieties.1  However, a number of these alkaloids 
have one of the linking ether bonds replaced by a biphenyl linkage.2  The bisbenzylisoquinoline 
alkaloids show a range of interesting biological activities.1  The related Thalictrum alkaloid, 
thalicarpine 1 (Figure 1),3 comprises the benzylisoquinoline, S-laudanosine, connected via an ether 
linkage to an aporphine moiety.  This molecule was found to have significant biological activity against 
the Walker 256 carcinoma and antiproliferative activity on a broad range of human and animal cell 
lines in vitro and in vivo.4,5  Initial clinical trails on this compound appeared encouraging,4-9 however 
phase II clinical trials stopped after no antitumour effect was observed.7,9    
Inspired by the structure and biological activity of thalicarpine we became interested in the synthesis of 
the novel laudanosine dimers of the type 2 and 3 (Figure 1), in which two laudanosine units are linked 
at C-2’ through a two or three-carbon linker (alkane, alkene or alkyne). In the example 3, a second 
three-carbon linker between the two isoquinoline N-atoms was also present leading to a macrocyclic 
ring system. This paper describes the successful synthesis of the racemic and meso forms of these 
target compounds, and in one case the pure (S,S)-enantiomer. 
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Figure 1 
 
2. Discussion 
Our approach to the target molecules 2 (alkene linker) was based on a Mizoroki-Heck coupling 
reaction of racemic N-trifluoroacetyl-2’-iodonorlaudanosine 410 and the racemic alkenes rac-5 and rac-
6.  The alkenes rac-5 and rac-6 were efficiently prepared from rac-4 using Stille coupling reactions 
(Scheme 1).  Palladium acetate gave slightly better yields of rac-5 and rac-6 (87% and 89%, 
respectively) than palladium chloride (79% and 82%, respectively). 
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Scheme 1 
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The Mizoroki-Heck coupling reaction of rac-4 and rac-5 using palladium acetate as the catalyst gave 
mixtures of the regioisomeric products rac-7 and rac-8 (Scheme 2).  These were difficult to separate by 
column chromatography.  These regioisomers were both isolated as mixtures of the racemic and meso 
forms (ca 55 : 45 to 60 : 40).  The formation of regioisomers in Mizoroki-Heck reactions on related 
substrates is well documented and has been shown to be dependent upon the steric and electronic 
nature of the substrates and the nature of the ligand, solvent, base and catalyst.11-20 The ratio of 7 and 8 
formed in these reactions was also dependent upon the reaction solvent, the ligand, and the nature of 
the base (Table 1). The combination of N,N-dimethylglycine (DMG), sodium acetate and N-
methylpyrrolidinone (NMP) at 130 oC for 18 h,  resulted in the best yields (combined yield of 66%)  
and regioselectivities for 7 over 8 (80 : 20, respectively) (Table 1, Entry 3). These conditions 
represented a significant improvement over the more traditional Heck conditions shown in Table 1, 
Entry 1. The use of silver salts increased the regioselectivity (90 : 10), but decreased the yield of 7 and 
8 significantly (Table 1, Entry 5).   The regioisomers 7 and 8 could not be easily separated by column 
chromatography.  On a preparative scale, using the conditions in Table 1, Entry 3, the major 
regioisomer 7 could be isolated pure (as a mixture of racemate and meso forms) by simply adding 
methanol to the reaction flask at the end of the reaction (Scheme 3). Pure rac/meso-7 precipitated out as 
a white solid in 54% yield. A small amount of meso-7 could be isolated by trituration of this white solid 
with dichloromethane in which meso-7 was much more soluble than rac-7.  This synthetic sequence 
4 
was repeated using (S)-421 and (S)-521 which allowed the unequivocal assignment of the (S,S)-, rac- and 
meso-forms of 7 (Figure 2).   Column chromatography of the initial mother liquors from which rac-7 
precipitated then gave pure regioisomer 8 (as a mixture of racemate and meso forms) in 12% yield 
(Scheme 3).   
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Table 1.  Mizoroki-Heck coupling reactions of 4 and 5 with Pd(OAc)2 at 130 
oC. 
Entry Additive Base Solvent 7 : 8b Yield 
(%)  
of 7 + 8c 
1 Ph3P
a Et3N MeCN 50 : 50 29 
2 Ph3P NaOAc NMP 60 : 40 50 
3 NMG NaOAc NMP 80 : 20 66 
4 - NaOAc NMP 40 : 60 54 
5 NMG NaOAc/ 
Ag3PO4 
NMP 90 : 10 24 
aReaction temperature 110 oC. bFrom 1H NMR analysis.  
cCombined yield of 7 and 8 after column chromatography. 
 
Base hydrolysis of rac/meso-7 and rac/meso-8 then gave rac/meso-9 and rac/meso-10, respectively 
(Scheme 2). A mixture of rac/meso-10 could be separated by preparative TLC. The stereochemistry of 
the individual isomers (whether rac or meso) however, could not be determined. 
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Figure 2. The 1H NMR spectra (300 MHz, CDCl3) of the mixture of meso-7 and rac-7 (top), (S,S)-7 
(middle) and meso-7 (bottom). 
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7 
Rac/meso-7 was found to be insoluble in most solvents commonly employed for hydrogenation 
reactions (e.g. MeOH, EtOH, EtOAc) but was found to be partially soluble in acetone. Hydrogenation 
of rac/meso-7 in acetone resulted in the selective hydrogenation of the more soluble rac-7.  After 
filtration of the catalyst, addition of methanol to the solution resulted in the precipitation of pure meso-
7 in 30% yield while further purification of the mother liquors by column chromatography gave rac-11 
in 35% yield (Scheme 3). Base hydrolysis of rac-11 then gave rac-12 in 95% yield (Scheme 3). 
Scheme 3 
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Under similar Mizoroki-Heck coupling reaction conditions to those described in Scheme 2, rac-4 and 
rac-6 underwent a Mizoroki-Heck coupling reaction to give 13 in 48% yield as ca 60 : 40 mixture of 
the racemic and meso forms (not necessarily respectively) (Scheme 4). This mixture was then 
converted to an inseparable mixture of rac/meso-14 upon base hydrolysis (Scheme 4). 
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Scheme 4  
 
 
 
 
 
 
 
 
 
 
A Sonagashira coupling reaction between rac-4 and trimethylsilylacetylene (3 equiv) gave a mixture of 
the desired product rac-15 (45%) and the undesired ene-yne rac-16 (52%) (Scheme 5).  The structure 
of the ene-yne rac-16 was based upon the downfield 1H NMR chemical shift of its alkene proton at  
8.15 (s, 1H).22-24  The alternative regioisomic product would be expected to have an alkene chemical 
shift at ca  7.0.22-24  When 1.5 equiv of trimethylsilylacetylene was employed the yield of rac-15 was 
92% (Scheme 5).  Rac-15 was converted to the primary alkyne rac-17 which underwent a Sonagashira 
coupling reaction with rac-4 to give rac/meso-18 in 49% yield.  The 1H and 13C NMR spectra of this 
compound indicated a single stereoisomer had formed (no doubling up of resonances was observed).  
This suggested that either the meso- or the rac- form of 18 had failed to form in this reaction or that 
either meso- or rac-18 was unstable to the reaction conditions and decomposed. A more likely 
explanation is that, because of the rigid alkyne tether, the two stereogenic centres in the isoquinoline 
ring are too remote to interact and thus the rac and meso forms of 18 have the same NMR chemical 
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shifts.  Base hydrolysis of rac/meso-18 gave rac/meso-19 in 79% yield.   The NMR spectra of 19 also 
did not show the doubling up of resonances.  
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Base hydrolysis of rac-6 gave the secondary amine rac-20 in 90% yield (Scheme 6) which was 
condensed with succinic anhydride to give the amido acid rac-21 in 79% yield. An amide coupling 
reaction between the acid rac-21 and the 2’-bromobenzylisoquinoline derivative rac-2224 gave the 
bisamide 23 as a mixture of the racemic and meso forms (Scheme 6). Attempts to convert rac/meso-23 
to the target macrocyclic compound 3 using the Mizoroki-Heck reaction conditions developed in 
Schemes 2 and 4 were unsuccessful and resulted in a complex mixture of products.  However, under 
the more traditional Heck reaction conditions (Pd(OAc)2, Ph3P, Et3N) the desired compound 3 was 
obtained in 15% yield.  NMR analysis of 3 indicated that a single isomer was obtained, with only one 
set of separate resonances observed for each different isoquinoline moiety. We made no attempts to 
determine whether this was the racemic or meso form of 3. The NMR evidence suggested that either 
the meso- or the rac- form of 3 had failed to form in this reaction or that either meso- or rac forms of 
23 or 3 were unstable to the reaction conditions and decomposed.  1H NMR analysis of 3 clearly 
indicated that the (E)-isomer of 3 was obtained ( 6.93 (d, 1H, J 15.3 Hz)). 
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Scheme 6 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
In summary, several novel laudanosine dimers in which two laudanosine units are linked at C-2’ via a 
two or three-carbon linker (alkane, alkene or alkyne) have been prepared using palladium-catalysed 
cross-coupling reactions. In one example, a second three-carbon linker between the two isoquinoline 
N-atoms was also present leading to the novel macrocyclic ring system 3. The biological activities of 
the N-deprotected bisisoquinoline compounds and the macrocyclic compound 3 will be reported in a 
separate publication.  
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3. Experimental 
3.1 General procedures 
Petrol refers to the fraction of petroleum spirit with a boiling point of 40-60 C.  All 1H NMR spectra 
were performed at 300 MHz and all 13C NMR (DEPT) spectra at 75 MHz in CDCl3 solution, unless 
otherwise noted. All spectra were referenced to CDCl3 (
1H  7.26 ppm and 13C NMR  77.00 ppm). 1H 
NMR assignments were achieved with the aid of gCOSY, and in some cases NOESY and TOCSY 
experiments. 13C NMR assignments were based upon DEPT, gHSQC and gHMBC experiments. All 
compounds were homogeneous by TLC analysis and judged to be of >95% purity based upon 1H NMR 
analysis. 
Compound numbering of isoquinoline derivatives is based on that of compound 7 as shown below. The 
numbering used for 3 in the NMR analysis in shown below in black, systematic numbering is shown in 
red. 
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3.2 General method for Stille coupling reactions. 
To a thick walled tube (sealed tube) containing a solution of the 2’-iodolaudanosine 4, PdCl2 and PPh3 
in dry DMF under N2 was added allyltributylstannane or tributylvinylstannane. The tube was sealed 
under a N2 atmosphere and the mixture was stirred and heated at 110 
0C for 36 h. The solution was 
cooled, diluted with CH2Cl2 and washed with H2O (4 x) and then brine. The CH2Cl2 layer was 
evaporated and the residue was redissolved in CH3CN and extracted with hexane. The CH3CN layer 
was evaporated and the residue was purified by column chromatography (EtOAc: petrol (1 : 1)) (unless 
indicated otherwise) to afford the pure products. 
 
 3.2.1 (RS) 1-(2’-Ethenyl-4’,5’-dimethoxyphenyl)methyl-2-trifluoroacetyl-1,2,3,4-tetrahydro-6,7-
dimethoxyisoquinoline (5). 
The 2’-iodolaudanosine derivative 4 (492 mg, 0.870 mmol), Pd(OAc)2 (16 mg, 0.071 mmol), PPh3 (43 
mg, 0.174 mmol) and tributylvinylstannane (333 mg, 1.04 mmol, 0.29 mL) in dry DMF (10 mL) under 
N2 was treated as described above using the general Stille coupling reaction conditions to afford a 
residue which was purified by column chromatography to afford 5 (352 mg, 87 %) as a yellow solid. 
The yellow solid was recrystallized from EtOAc : petrol (1 : 1) and was a 95 : 5 mixture of rotamers. Rf 
0.48 (EtOAc: petrol (1 : 1)). M.p. 132-134 0C. 1H NMR of the major rotamer (500 MHz):  6.97 (s, 1H, 
H3’), 6.81 (dd, 1H, J 17.0, 11.0 Hz, H1’’), 6.56 (s, 1H, H8), 6.39 (s, 1H, H5), 6.08 (s, 1H, H6’), 5.50 (t, 
1H, J 7.0 Hz, H1), 5.46 (d, 1H, J 17.0 Hz, H2’’(E)), 5.13 (d, 1H, J 11.0 Hz, H2’’(Z)), 3.87 (dt, 1H, J 
9.0, 4.0 Hz, H3), 3.87 (s, 3H, OCH3-4’), 3.82 (s, 3H, OCH3-6), 3.70 (s, 3H, OCH3-7), 3.63-3.61 (m, 
1H, H3), 3.57 (s, 3H, OCH3-5’), 3.16 (d, 2H, J 7.0 Hz, H7’), 2.92-2.83 (m, 1H, H4), 2.71 (m, 1H, H4). 
1H NMR of the minor rotamer (in part):  6.57 (s, 1H, H8), 6.41 (s, 1H, H5), 5.84 (s, 1H, H6’), 3.84 (s, 
14 
3H, OCH3-4’), 3.84 (s, 3H, OCH3-6), 3.78 (s, 3H, OCH3-7), 3.51 (s, 3H, OCH3-5’). 
13C NMR of the 
major rotamer (125 MHz): (signals for COCF3 and COCF3 were not observed)  148.8 (C4’), 148.5 
(C6), 148.3 (C7), 147.6 (C5’), 133.9 (CH-1’’), 130.4 (C2’), 127.3 (C4a), 126.4 (C8a), 125.4 (C1’), 
114.5 (CH2-2’’), 114.1 (CH-3’), 111.2 (CH-5), 111.0 (CH-8), 108.5 (CH-6’), 56.2 (OCH3-4’), 56.2 
(OCH3-6), 56.1 (OCH3-7), 56.0 (OCH3-5’), 55.6 (CH-1), 41.0 (CH2-3), 38.2 (CH2-7’), 28.7 (CH2-4). 
MS (ESI+) m/z 466.1 (MH+, 50 %). HRMS (EI+): calcd for C24H26NO5F3, 465.1763 (M
+). Found 
465.1762. 
 
3.2.2 (RS) 2-Trifluoroacetyl-1,2,3,4-tetrahydro-1-(4’,5’-dimethoxy-2’-(2’’-propenyl)-
phenyl)methyl-6,7-dimethoxyisoquinoline  (6). 
The 2’-iodolaudanosine derivative 4 (711 mg, 1.26 mmol), Pd(OAc)2 (23 mg, 0.102 mmol), PPh3 (61 
mg, 0.232 mmol), allyltributylstannane (499 mg, 1.51 mmol, 0.46 mL) and dry DMF (5 mL) under N2 
was treated as described above using the general Stille coupling reaction conditions to afford an oil 
which was purified by column chromatography to give 68 (536 mg, 89 %) as a white solid. Compound 
6 was recrystallized from diethyl ether and was a 95 : 5 mixture of rotamers. Rf 0.63 (EtOAc : petrol (1 
: 1)). M.p. 140-144 0C. 1H NMR of the major rotamer:  6.62 (s, 1H, H3’), 6.58 (s, 1H, H5), 6.53 (s, 
1H, H6’), 6.00 (s, 1H, H8), 5.91-5.78 (m, 1H, H2’’), 5.49 (dd, J 8.1, 6.0 Hz, 1H, H1), 5.02 (dd, 1H, J 
10.2, 0.9 Hz, H3’’(Z)), 4.94 (dd, 1H, J 17.2, 0.9 Hz, H3’’(E)), 3.85 (s, 3H, OCH3-4’), 3.84 (s, 3H, 
OCH3-6), 3.98-3.92 (m, 1H, H3), 3.76 (s, 3H, OCH3-7), 3.74-3.64 (m, 1H, H3), 3.56 (s, 3H, OCH3-5’), 
3.12 (dd, 2H, J 4.8, 1.5 Hz, H1’’), 3.04 (d, 1H, J 6.0 Hz, H7’), 3.03 (d, 1H, J 8.1 Hz, H7’), 2.96-2.88 
(m, 1H, H4), 2.83-2.75 (m, 1H, H4). 1H NMR of the minor rotamer (in part):  6.55 (s, 1H, H8), 3.80 
(s, 3H, OCH3-6), 3.49 (s, 3H, OCH3-5’). 
13C NMR of the major rotamer: (signals for COCF3 and 
COCF3 were not observed),  148.4 (C4’), 148.1 (C6), 147.4 (C7), 147.4 (C5’), 137.5 (CH-2’’), 131.2 
(C2’), 127.4 (C4a), 126.6 (C8a), 125.1 (C1’), 115.9 (CH2-3’’), 114.2 (CH-3’), 113.1 (CH-5), 111.2 
(CH-8), 110.9 (CH-6’), 56.2 (OCH3-4’), 56.1 (OCH3-6), 55.8 (OCH3-7, OCH3-5’), 55.6 (CH-1), 40.8 
15 
(CH2-3), 39.1 (CH2-1’’), 36.7 (CH2-7’), 28.7 (CH2-4). 
13C NMR of the minor rotamer (in part):  114.9 
(CH-3’), 113.8 (CH-5), 111.5 (CH-8), 111.4 (CH-6’), 27.4 (CH2-4). MS (CI
+): m/z 480 (MH+, 100 %). 
HRMS (CI+): calcd for C25H29NO5F3, 480.1998 (MH
+). Found 480.2000. 
 
3.3 General method for Mizoroki-Heck coupling reactions. 
A mixture of palladium acetate, N,N-dimethylglycine (DMG), sodium acetate and both coupling 
partners were placed in a thick walled tube (sealed tube) under N2. Dry N-methylpyrolidinone (NMP) 
was added and the reaction mixture was bubbled with argon prior to sealing the tube. The reaction 
mixture was heated at 130 0C for 18 h. The reaction mixture was cooled and then diluted with CH2Cl2 
and the solution was washed with H2O (3 x), brine and dried (MgSO4). The solution was evaporated to 
give a dark oil that was purified by column chromatography (EtOAc : petrol (1 : 1)) (unless otherwise 
stated) to give the desired product. 
3.3.1 (1RS, 1`RS) and (R, S) (E) 2’,2``-(1’’,2’’-Ethenediyl)-bis-[2-trifluoroacetyl-1,2,3,4-
tetrahydro-6,7-dimethoxy-1-(4’,5’-dimethoxyphenyl)methyl]isoquinoline (7) and (1RS, 1`RS) (E) 
2’,2``-(1’’,1’’-Ethenediyl)-bis-[2-trifluoroacetyl-1,2,3,4-tetrahydro-6,7-dimethoxy-1-(4’,5’-
dimethoxyphenyl)methyl]isoquinoline (8). 
The 2’-iodolaudanosine derivative 4 (203 mg, 0.354 mmol), the 2’-vinyllaudanosine derivative 
5 (166 mg, 0.354 mmol), Pd(OAc)2 (8 mg, 0.035 mmol), DMG (73 mg, 0.708 mmol), NaOAc (56 mg, 
0.708 mmol) and dry NMP (5 mL) under N2 were treated as described above in the general Mizoroki-
Heck coupling reaction procedure to give a crude mixture. To the mixture was added methanol (5 mL) 
and the product 7 precipitated out as a white solid (164 mg, 54 %). The regioisomer 8 remained in the 
solution and was purified by column chromatography (CH2Cl2 : EtOAc : petrol (3 : 2 : 3)) to give 8 (36 
mg, 12 %) as a yellow oil. Compound 7 was a 55 : 45 mixture of diastereomers. Compound 8 was a 60 
16 
: 40 mixture of diastereomers. A minor rotamer (~ 5 %) was also observed in the 1H NMR spectra of 
both 7 and 8.  
Compounds 7 and 8 were also prepared according to the conditions outlined in Table 1 under, 
essentially, the same conditions using the quantities of catalyst, base and additives shown in the Table. 
A small amount of (S,S)-7 (13 mg, 15 %) was obtained under the same Mizoroki-Heck coupling 
reaction conditions using a mixture of (S)-5 (60 mg, 0.105 mmol) and (S)-4 (80 mg, 0.171 mmol), 
Pd(OAc)2 (3 mg, 0.013 mmol), DMG (27 mg, 0.258 mmol), NaOAc (21 mg, 0.258 mmol) and NMP (2 
mL). A mixture of (S)-5 and (S)-4 (67 mg) was also recovered. Compound (S,S)-8 was also observed in 
the reaction, however, not in significant quantity or purity to characterize.  
7: Rf 0.31 (CH2Cl2 : EtOAc : petrol (3 : 2 : 3)). (S,S)-7: 
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D][  + 29 (0.84, CHCl3). M.p. (meso-7 and 
rac-7 ) 226-228 0C. 1H NMR of the major diastereomer, meso-7:  7.58 (s, 4H, CH=CH, H3’, H3``), 
6.58 (s, 2H, H5, H5`), 6.05 (s, 2H, H6’, H6``), 5.91 (s, 2H, H8, H8`), 5.47 (dd, 2H, J 9.5, 5.4 Hz, H1, 
H1`), 4.05 (s, 6H, OCH3-5’, OCH3-5``), 3.85 (dd, 2H, J 8.1, 3.9 Hz, H3, H3`), 3.81 (s, 6H, OCH3-4’, 
OCH3-4``), 3.71-3.65 (m, 2H, H3, H3`),  3.57 (s, 6H, OCH3-6, OCH3-6`), 3.53 (t, 2H, J 13.2, 5.4 Hz, 
H7’, H7``), 3.47 (s, 6H, OCH3-7, OCH3-7`), 2.99 (dd, 2H, J 13.2, 9.5 Hz, H7’, H7``), 2.92-2.86 (m, 2H, 
H4, H4`),  2.81-2.76 (m, 2H, H4, H4`). 1H NMR of the minor rotamer of meso-7 (in part):  7.45 (s, 
2H, H3’, H3``), 7.53 (s, 2H, CH=CH), 5.79 (s, 2H, H8, H8`), 6.48 (s, 2H, H5, H5`). 3.76 (s, 6H, OCH3-
5’, OCH3-5``), 3.71 (s, 6H, OCH3-4’, OCH3-4``), 3.60 (s, 6H, OCH3-6, OCH3-6`), 3.42 (s, 6H, OCH3-
7, OCH3-7`). 
13C NMR of the major diastereomer, meso-7:  156.1 (q, J 35.5 Hz, COCF3), 148.9 (C5’, 
C5``), 148.3 (C4’, C4``), 148.2 (C6, C6`), 147.1 (C7, C7`), 130.0 (C1’, C1``), 127.1 (C2’, C2``), 126.1 
(C4a, C4a`), 125.5 (C8a, C8a`), 125.0 (CH=CH), 115.2 (CH-6’, CH-6``), 113.5 (q, J 270.1 Hz, 
COCF3), 111.9 (CH-8, CH-8`), 111.1 (CH-5, CH-5`), 108.5 (CH-3’, CH-3``), 56.1 (OCH3-4’, OCH3-
4``, OCH3-6, OCH3-6`, OCH3-7, OCH3-7`), 55.8 (OCH3-5’, OCH3-5``), 55.5 (CH-1, CH-1`), 41.4 
(CH2-3, CH-3`),  38.9 (CH2-7’, CH2-7``), 28.6 (CH2-4, CH2-4`). 
1H NMR of the minor diastereomer, 
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rac-7:  7.56 (s, 2H, CH=CH), 7.51 (s, 2H, H3’, H3``), 6.54 (s, 2H, H5, H5`), 6.09 (s, 2H, H6’, H6``), 
5.80 (s, 2H, H8, H8`), 5.43 (dd, 2H, J 10.5, 3.3 Hz, H1, H1`), 3.99 (s, 6H, OCH3-5’, OCH3-5``), 3.80 
(m, 2H, H3, H3`), 3.76 (s, 6H, OCH3-4’, OCH3-4``), 3.60 (s, OCH3-6, OCH3-6`), 3.49 (m, 2H, H3’, 
H3`),  3.42 (s, OCH3-7, OCH3-7`), 3.38 (m, 2H, H7’, H7``), 2.93 (dd, 2H, J 13.2, 10.5 Hz, H7’, H7``), 
2.91 (m, 2H, H4, H4`), 2.86 (m, 2H, H4, H4`). 13C NMR of the minor diastereomer, rac-7:  156.1 (q, 
J 35.5 Hz, COCF3), 148.9 (C5’, C5``), 148.3 (C4’, C4``), 148.2 (C6, C6`), 147.1 (C7, C7`), 130.0 (C1’, 
C1``), 127.1 (C2’, C2``), 126.1 (C4a, C4a`), 125.5 (C8a, C8a`), 125.0 (CH=CH), 115.2 (CH-6’, CH-
6``), 113.5 (q, J 270.1 Hz, COCF3), 111.9 (CH-8, CH-8`), 111.1 (CH-5, CH-5`), 108.5 (CH-3’, CH-
3``), 56.1 (OCH3-4’, OCH3-4``, OCH3-6, OCH3-6`, OCH3-7, OCH3-7`), 55.8 (OCH3-5’, OCH3-5``), 
55.5 (CH-1, CH-1`), 41.4 (CH2-3, CH-3`),  38.9 (CH2-7’, CH2-7``), 28.6 (CH2-4, CH2-4`). MS (ESI
+): 
m/z 925.1 (M+Na+, 100 %). HRMS (ESI+): calculated for C46H49N2O10F6, 903.3291 (MH
+). Found 
903.3251. 
8: Rf 0.25 (CH2Cl2 : EtOAc : petrol (3 : 2 : 3)). 
1H NMR of the major diastereomer, rac-8:  6.61 (s, 
2H, H3’, H3``), 6.52 (s, 4H, H5, H5`, H6’, H6``), 5.94 (s, 2H, H8, H8`), 5.39 (t, 2H, J 7.5 Hz, H1, 
H1`), 4.95 (s, 2H, C=CH2), 3.84 (s, 6H, OCH3-5’, OCH3-5``), 3.82 (s, 6H, OCH3-4’, OCH3-4``), 3.74 
(s, 6H, OCH3-6, OCH3-6`), 3.76-3.70 (m, 2H, H3, H3`), 3.56 (s, 6H, OCH3-7, OCH3-7`), 3.33-3.10 (m 
2H, H3, H3`), 2.95-2.76 (m, 4H, H7’, H7``, H4, H4`), 2.70-2.53 (m, 4H, H7’, H7``, H4, H4`). 1H NMR 
of the minor diastereomer, meso-8 (in part):  6.65 (s, 2H, H3’, H3``), 6.56 (s, 2H, H5, H5`), 5.92 (s, 
2H, H8, H8`), 5.49 (s, 2H, H1, H1`), 4.78 (s, 2H, C=CH2), 3.79 (s, 6H, OCH3-5’, OCH3-5``), 3.78 (s, 
6H, OCH3-4’, OCH3-4``), 3.76 (s, 6H, OCH3-6, OCH3-6`), 3.51 (s, 6H, OCH3-7, OCH3-7`). 
13C NMR 
of the major diastereomer, rac-8:  155.9 (q, J 35.0 Hz, COCF3), 148.6 (C4’, C4``), 148.5 (C6, C6`), 
147.9 (C5’, C5``), 147.8 (C7, C7`), 135.7 (C=CH2), 127.4 (C1’, C1``, C2’, C2``), 126.9 (C4a, C4a`), 
125.0 (C8a, C8a`), 120.8 (C=CH2), 114.1 (CH-3’, CH-3``), 113.8 (CH-5, CH-5`), 112.5 (q, J 224.8 Hz, 
COCF3), 111.2 (CH-6, CH-6`), 110.4 (CH-8, CH-8`), 56.2 (OCH3-4’, OCH3-4``), 56.2 (OCH3-6, 
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OCH3-6`), 56.1 (OCH3-5’, OCH3-5``), 55.7 (OCH3-7, OCH3-7`), 55.4 (CH-1, CH-1`), 41.4 (CH2-3, 
CH2-3`), 38.1 (CH2-7’, CH2-7``), 28.8 (CH2-4, CH2-4`). 
13C NMR of the minor diastereomer, meso-8 
(in part):  135.8 (C=CH2), 127.3 (C1’, C1``, C2’, C2``), 124.8 (C8a, C8a`), 120.5 (C=CH2), 38.0 
(CH2-7’, CH2-7``). MS (ESI
+): m/z 925.0 (M+Na+, 20 %). HRMS (ESI+): calculated for C46H49N2O10F6, 
903.3291 (MH+). Found 903.3315. 
3.3.2 (1RS, 1`RS) and (R, S) (E) 2’,2``-(1’’,3’’-Prop-2’’-enediyl)-bis-[2-trifluoroacetyl-1,2,3,4-
tetrahydro-6,7-dimethoxy-1-(4’,5’-dimethoxyphenyl)methyl]isoquinoline (13). 
The 2’-iodolaudanosine derivative 4 (255 mg, 0.462 mmol), the 2’-allyllaudanosine derivative 6 (232 
mg, 0.462 mmol), Pd(OAc)2 (12 mg, 0.046 mmol), DMG (95 mg, 0.927 mmol), NaOAc (73 mg, 0.927 
mmol) and dry NMP (5 mL) were treated as described above using the general Heck coupling reaction 
procedure to give a dark oil. The oil was purified by column chromatography to give the desired 
product 13 (199 mg, 48 %) as a yellow solid. Product 13 was a 60 : 40 mixture of diastereomers and a 
minor rotamer (~ 5 %) was also observed in the 1H NMR spectrum. Rf  0.19 (EtOAc : petrol (1 : 1)). 
M.p. 102-104 0C. 1H NMR of the major diastereomer:  6.86 (s, 1H, H3``) 6.68 (s, 1H, H3’), 6.56 (s, 
1H, H5), 6.53 (s, 1H, H5``), 6.48 (s, 1H, H6’), 6.42 (d, 1H, J 14.1 Hz, H3’’), 6.37 (s, 1H, H6``), 5.97 (s, 
2H, H8, H8`), 5.97-5.92 (m, 1H, H2’’), 5.47 (dd, 2H, J 8.7, 5.7 Hz, H1, H1`), 3.91-3.83 (m, 2H, H3, 
H3`), 3.79 (s, 12H, OCH3-6, OCH3-6`, OCH3-4’, OCH3-4``), 3.55-3.50 (m, 2H, H3, H3`), 3.70 (s, 6H, 
OCH3-7, OCH3-7`), 3.48 (s, 6H, OCH3-5’, OCH3-5``), 3.32-3.18 (m, 2H, H1’’), 3.12-2.99 (m, 4H, H7’, 
H7``), 2.87-2.77 (m, 2H, H4, H4`), 2.73-2.65 (m, 2H, H4, H4`). 1H NMR of the minor diastereomer (in 
part):  6.85 (s, 1H, H3``), 6.67 (s, 1H, H3’), 6.56 (s, 1H, H5), 6.53 (s, 1H, H5``), 6.47 (s, 1H, H6’), 
6.42 (d, 1H, J 14.1 Hz, H3’’), 6.36 (s, 1H, H6``), 6.00 (s, 1H, H8), 5.92 (s, 1H, H8`), 5.43 (dd, 2H, J 
8.7, 5.7 Hz, H1, H1`), 3.74 (s, 12H, OCH3-6, OCH3-6`, OCH3-4’, OCH3-4``), 3.66 (s, 6H, OCH3-7, 
OCH3-7`), 3.46 (s, 6H, OCH3-5’, OCH3-5``). 
13C NMR of the major diastereomer:  155.9 (q, J 36.1 
Hz, COCF3), 148.2 (C6, C6`), 148.1 (C4’, C4``), 147.3 (C5’, C5``), 147.1 (C7, C7`), 131.5 (C1``), 
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129.8 (C1’), 129.5 (CH-3’’), 127.5 (CH-2’’), 127.1 (C2``),  126.5 (C2’), 126.2 (C4a`), 126.0 (C4a), 
125.1 (C8a`), 125.0 (C8a), 114.1 (q, J 286.5 Hz, COCF3), 114.0 (CH-6’), 133.8 (CH-6``), 113.0 (CH-
3’), 110.9 (CH-5, CH-5`),  110.6 (CH-8, CH-8`), 108.5 (CH-3``), 55.8 (8 x OCH3), 55.3 (CH-1, CH-
1`), 40.6 (CH2-3, CH2-3`), 38.0 (CH2-7’, CH2-7``), 36.0 (CH2-1’’), 28.4 (CH2-4, CH2-4`). 
13C NMR of 
the minor diastereomer (in part):  148.1 (C6, C6`), 147.9 (C4’, C4``), 147.1 (C5’, C5``), 147.0 (C7, 
C7`), 131.5 (C1``), 129.8 (C1’), 129.7 (CH-3’’), 127.6 (CH-2’’), 127.2 (C2``), 126.5 (C2’), 126.3 
(C4a`), 126.0 (C4a), 125.1 (C8a`), 125.0 (C8a), 114.0 (CH-6’), 133.7 (CH-6``), 113.1 (CH-3’), 110.8 
(CH-5, CH-5`), 110.7 (CH-8, CH-8`), 108.4 (CH-3``), 40.6 (CH2-3, CH2-3`), 37.9 (CH2-7’, CH2-7``), 
36.1 (CH2-1’’), 28.5 (CH2-4, CH2-4`). MS (ESI
+) m/z 916.72 (MH+, 10 %), m/z 954.74 (M+K+, 100 %). 
HRMS (ESI+) calcd for C47H51N2O10F6, 917.3448 (MH
+). Found 917.3451.  
 
3.4 General method for hydrogenation reactions. 
3.4.1 (1RS, 1`RS) and (R,S)  2’,2``-(1’’,2’’-Ethanediyl)-bis-[2-trifluoroacetyl-1,2,3,4-tetrahydro-
6,7-dimethoxy-1-(4’,5’-dimethoxyphenyl)methyl]isoquinoline (11). 
To a solution of alkene 7 (73 mg, 0.083 mmol) in acetone (80 mL) was added 10 % Pd/C (10 mg) in a 
round bottom flask sealed with a suba seal. The flask was purged with nitrogen and then a hydrogen 
filled balloon was secured on top of the flask, allowing the hydrogen to circulate inside the flask. The 
reaction mixture was stirred at RT for 3 d under a H2 atmosphere. Nitrogen was then bubbled into the 
solution for 2 min and CH2Cl2 (1 mL) was added until the solution became completely homogenous.  
Pd/C was filtered and the solvent was evaporated to give a crude mixture of meso-7 and rac-11. The 
crude mixture was dissolved in CH2Cl2 (1 mL) and methanol (4 mL) was added slowly resulting in the 
precipitation of meso-7. The pure meso-7 (22 mg, 30 %) was filtered as a white solid. The filtrate was 
evaporated and then purification by column chromatography (CH2Cl2 : EtOAc : petrol (3 : 2 : 3)) gave 
pure rac-11 (26 mg, 35 %) a yellow oil. 
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11: Rf 0.39 (CH2Cl2 : EtOAc : petrol (3 : 2 : 3)). 
1H NMR:  6.62 (s, 2H, H3’, H3``), 6.57 (s, 2H, H5, 
H5`), 6.30 (s, 2H, H6’, H6``), 5.90 (s, 2H, H8, H8`), 5.40 (dd, 2H, J 8.4, 5.1 Hz, H1, H1`), 3.93-3.85 
(m, 2H, H3, H3`),  3.82 (s, 6H, OCH3-4’, OCH3-4``), 3.79 (s, 2H, OCH3-5’, OCH3-5``), 3.66 (s, 2H, 
OCH3-6, OCH3-6`), 3.64-3.55 (m, 2H, H3, H3`), 3.48 (s, 6H, OCH3-7, OCH3-7`), 2.94 (dd, 2H, J 13.5, 
5.1 Hz, H7’, H7``), 2.82 (s, 4H, H1’’, H2’’), 2.81 (dd, 2H, J 13.5, 8.4 Hz, H7’, H7``), 2.78-2.62 (m, 
4H, H4,  H4`). 
13C NMR: (signals for COCF3 and COCF3 were not observed),  148.1 (C4’, C4``), 
147.8 (C6, C6`), 147.0 (C5’, C5``), 146.8 (C7, C7`), 132.7 (C2’, C2``), 126.8 (C1’, C1``), 126.1 (C4a, 
C4a`), 124.9 (C8a, C8a`), 114.2 (CH-6’, CH-6``), 112.9 (CH-3’, CH-3``), 110.9 (CH-5, CH-5`), 110.8 
(CH-8, CH-8`), 55.8 (8 x OCH3), 55.5 (C1, C1`), 40.7 (CH2-3, CH2-3`), 38.0 (CH2-7’, CH2-7``), 33.5 
(CH2-1’’, CH2-2’’), 29.0 (CH2-4, CH2-4`). MS (ESI
+): m/z 905.1 (MH+, 20 %). HRMS (ESI+): calcd for 
C46H51N2O10F6, 905.3448 (MH
+). Found 905.3411. 
 
3.5 General method for Sonagashira coupling Reactions. 
3.5.1 (RS) 2-Trifluoroacetyl-1,2,3,4-tetrahydro-6,7-dimethoxy-1-(4’,5’-dimethoxy-2’-
(trimethylsilylethynyl)phenyl)methylisoquinoline  (15). 
Compound 4 (300 mg, 0.530 mmol), PdCl2 (5 mg, 0.027 mmol), PPh3 (14 mg, 0.053 mmol) and CuI 
(10 mg, 0.053 mmol) were added to a dry flask under a N2 atmosphere. Dry THF (45 mL) was added 
followed by the addition of Et3N (80 mg, 0.795 mmol, 0.11 mL). The solution was stirred for 5 min 
before trimethylsilylacetylene (78 mg, 0.795 mmol, 0.11 mL) was added. The reaction was stirred at rt 
for 4 d. The solvent was evaporated and the crude mixture was purified by column chromatography 
(CH2Cl2 : EtOAc : petrol (3 : 1 : 3)) to give 15 (266 mg, 92 %) as a brown solid.  Compound 15 was a 
95 : 5 mixture of rotamers. Rf 0.77 (CH2Cl2 : EtOAc : petrol (3 : 1: 3)). M.p. 114-118 
0C. 1H NMR of 
the major rotamer:  6.85 (s, 1H, H3’), 6.65 (s, 1H, H6’), 6.56 (s, 1H, H5), 6.33 (s, 1H, H8), 5.66 (t, 
1H, J 7.2, 6.9 Hz, H1), 3.93 (dt, 1H, J 12.0, 4.5 Hz, H3), 3.82 (s, 6H, OCH3-4’ and OCH3-5’), 3.78 (s, 
3H, OCH3-6), 3.69 (s, 3H, OCH3-7), 3.63 (dt, 1H, J 11.7, 4.5 Hz, H3), 3.42 (dd, 1H, J 13.5, 6.9 Hz, 
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H7’), 3.13 (dd, 1H, J 13.5, 7.2 Hz, H7’), 2.95-2.85 (m, 1H, H4), 2.74-2.66 (m, 1H, H4), 0.16 (s, 9H, 
Si(CH3)3). 
13C NMR of the major rotamer:  155.4 (q, J 34.3 Hz, COCF3), 149.4 (C4’), 148.3 (C5’), 
147.6 (C6), 147.5 (C7), 132.5 (C2’), 126.8 (C1’), 124.9 (C4a), 115.7 (C8a), 114.6 (CH-3’), 114.5 (q, J 
204.9 Hz, COCF3), 112.3 (CH-6’), 111.1 (CH-5), 110.4 (CH-8), 103.7 (ArCCSi(CH3)3), 95.9 
(CSi(CH3)3), 56.0 (OCH3-4’), 55.9 (OCH3-5’, OCH3-6 and OCH3-7), 54.7 (CH-1),  40.3 (CH2-3), 39.5 
(CH2-7’), 28.7 (CH2-4), 0.1 (Si(CH3)3). 
13C NMR of the minor rotamer (in part):  40.7 (CH2-3), 37.9 
(CH2-7’), 27.3 (CH2-4). MS (CI
+): m/z 536 (MH+, 10 %). HRMS (EI+): calcd for C27H32NO5F3Si, 
535.2002 (M+). Found 535.1984. 
 
3.5.2 (R,S) 2-Trifluoroacetyl-1,2,3,4-tetrahydro-6,7-dimethoxy-1-(4’,5’-dimethoxy-2’-(2’’-
trimethylsilyl-2’’-(trimethylsilylethynyl)ethenyl)phenyl)methylisoquinoline  (16). 
Compound 4 (300 mg, 0.530 mmol), PdCl2 (4.5 mg, 0.027 mmol), PPh3 (13.6 mg, 0.053 mmol) and 
CuI (10 mg, 0.053 mmol) were added to a dry flask under a N2 atmosphere. Dry THF (45 mL) was 
added to the mixture followed by the addition of Et3N (161 mg, 1.59 mmol, 0.11 mL). The solution 
was stirred for 5 min before trimethylsilylacetylene (158 mg, 1.59 mmol, 0.22 mL) was added. The 
reaction was stirred at rt for 4 d. The solvent was evaporated and the crude mixture was purified by 
column chromatography (CH2Cl2 : EtOAc : petrol (3 : 1 : 3)) to give 16 (175 mg, 52 %) as a brown oil, 
and  15 (130 mg, 45 %) as a brown solid.  
16: Rf 0.74 (CH2Cl2 : EtOAc : petrol (3 : 1: 1)). 
1H NMR:  8.15 (s, 1H, H1’’), 6.66 (s, 1H, H3’), 6.56 
(s, 2H, H6’, H5), 5.97 (s, 1H, H8), 5.45 (dd, 1H, J 8.4, 5.4 Hz, H1), 3.88 (s, 3H, OCH3-4’), 3.84-3.80 
(m, 1H, H3), 3.82 (s, 3H, OCH3-5’), 3.77 (s, 3H, OCH3-6), 3.70-3.59 (m, 1H, H3), 3.52 (s, 3H, OCH3-
7), 3.18 (dd, 1H, J 13.5, 8.4 Hz, H7’), 3.12 (dd, 1H, J 13.5, 5.4 Hz, H7’), 2.95-2.85 (m, 1H, H4), 2.78-
2.70 (m, 1H,  H4), 0.16 (s, 9H, Si(CH3)3), 0.13 (s, 9H, Si(CH3)3). 
13C NMR:  (signals for COCF3 and 
COCF3  were not observed),  149.1 (C4’), 148.5 (C5’, C6), 147.5 (C7), 141.3 (CH-1’’), 129.9 (C2’), 
128.7 (C1’), 126.1 (C4a), 125.1 (C8a), 123.2 (C2’’), 113.6 (CH-3’), 111.4 (CH-6’), 111.1 (CH-5, CH-
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8), 110.7 (CCSi(CH3)3), 106.4 (CCSi(CH3)3), 56.0 (4 x OCH3, CH-1), 41.1 (CH2-3), 37.9 (CH2-7’), 
28.6 (CH2-4), 0.35 (Si(CH3)3), 0.10 (Si(CH3)3). MS (ESI
+): m/z 634 (MH+, 100 %). HRMS (ESI+): 
calcd for C24H24NO5F3, 634.2653 (MH
+). Found 634.2610. 
 
3.5.3 (RS) 2-Trifluoroacetyl-1,2,3,4-tetrahydro-6,7-dimethoxy-1-(4’,5’-dimethoxy-2’-
ethynylphenyl)methylisoquinoline (17). 
A mixture of 15 (130 mg, 0.240 mmol) in CH3OH (2 mL) and H2O (0.5 mL) was added KF (150 mg, 
2.59 mmol). The suspension was stirred at rt for 18 h. The solvent was evaporated and the residue was 
redissolved in EtOAc. The reaction mixture was washed with 0.1 M HCl then brine and dried 
(MgSO4). The solvent was evaporated to give an oil which was purified by column chromatography 
(CH2Cl2 : EtOAc : petrol (3 :1: 4)) to give 17 (60 mg, 54 % yield) as a brown oil. Compound 17 was a 
95 : 5 mixture of rotamers.  Rf  0.38 (CH2Cl2 : EtOAc : petrol (3 : 1 : 4)). 
1H NMR of the major 
rotamer:  6.95 (s, 1H, H3’), 6.59 (s, 1H, H6’), 6.56 (s, 1H, H5), 6.55 (s, 1H, H8), 5.76 (dd, J 7.8, 5.7 
Hz, H1), 3.98 (dd, 1H, J 13.5, 4.8 Hz, H3), 3.86 (s, 6H, OCH3-4’ and OCH3-5’), 3.75 (s, 6H, OCH3-6 
and OCH3-7), 3.68-3.58 (m, 1H, H3), 3.47 (dd, 1H, J 13.8, 5.7, H7’), 3.17 (dd, 1H, J 13.8, 7.8 Hz, 
H7’), 3.16 (s, 1H, ArCCH), 2.96-2.87 (m, 1H, H4), 2.73-2.65 (m, 1H, H4). 1H NMR of the minor 
rotamer (in part):  6.97 (s, 1H, H3’), 6.61 (s, 1H, H6’), 6.43 (s, 1H, H5), 6.36 (s,1H, H8). 13C NMR of 
the major rotamer:  155.8 (q, J 34.3 Hz, COCF3), 149.7 (C4’), 148.4 (C5’), 147.9 (C6), 147.8 (C7), 
133.2 (C2’), 127.1 (C1’), 125.3 (C4a), 115.0 (CH-3’), 114.5 (C8a), 114.0 (q, J 225.1 Hz, COCF3), 
112.7 (CH-6’), 111.2 (CH-5), 110.4 (CH-8), 82.6 (ArCCH), 79.6 (ArCCH), 56.1 (3 x OCH3), 56.0 
(OCH3-7), 54.8 (CH-1), 40.4 (CH2-3), 39.8 (CH2-7’), 28.9 (CH2-4). MS (CI
+): m/z 464.1 (MH+, 100 
%). HRMS (EI+): calcd for C24H24NO5F3, 463.1607 (M
+). Found 463.1606. 
 
3.5.4 (1RS, 1`RS) and (R,S) 2’,2``-(1’’,2’’-Ethynediyl)-bis-[2-trifluoroacetyl-1,2,3,4-tetrahydro-
6,7-dimethoxy-1-(4’,5’-dimethoxyphenyl)methyl]isoquinoline (18). 
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To a mixture of 2’-iodolaudanosine 4 (144 mg, 0.255 mmol), 17 (118 mg, 0.255 mmol), PdCl2 (2 mg, 
0.0127 mmol), PPh3 (7 mg, 0.026 mmol) and CuI (5 mg, 0.026 mmol) under a N2 atmosphere was 
added distilled THF (10 mL). Et3N (39 mg, 0.383 mmol, 0.051 mL) was subsequently added and the 
mixture was stirred at rt for 24 h. The solvent was evaporated and the residue was purified by column 
chromatography (CH2Cl2 : CH3OH : petrol (3 :1 : 4)) to give 18 (113 mg, 49 %) as a white solid. 
Compound 18 was a 95 : 5 mixture of rotamers.  Rf 0.26 (CH2Cl2 : CH3OH : petrol (3 : 1: 4)). M.p. 
168-172 0C. 1H NMR of the major rotamer:  7.17 (s, 2H, H3’, H3``), 6.63 (s, 2H, H6’, H6``), 6.58 (s, 
2H, H5, H5`), 6.51 (s, 2H, H8, H8`), 5.69 (dd, 2H, J 8.0, 6.0 Hz, H1, H1`), 4.02 (bd, 2H, J 13.5 Hz, H3, 
H3`), 3.84 (s, 6H, OCH3-4’, OCH3-4``), 3.82 (s, 2H, OCH3-5’, OCH3-5``), 3.76 (s, 2H, OCH3-6, 
OCH3-6`), 3.73 (s, 6H, OCH3-7, OCH3-7`), 3.72-3.66 (m, 2H, H3, H3`), 3.26 (dd, 2H, J 14.1, 6.0 Hz, 
H7’, H7``), 3.13 (dd, 2H, J 14.1, 8.0 Hz, H7’, H7``), 2.99-2.89 (m, 2H, H4, H4`),  2.81-2.73 (m, 2H, 
H4, H4`). 1H NMR of the minor rotamer (in part):  6.66 (s, 2H, H6’, H6``), 6.59 (s, 2H, H5, H5`), 6.50 
(s, 2H, H8, H8`), 5.05 (s, 2H, H1, H1`). 13C NMR of the major rotamer:  155.5 (q, J 38.4 Hz, COCF3), 
150.3 (C4’, C4``), 148.5 (C5’, C5``), 148.1 (C6, C6`), 147.9 (C7, C7`), 134.5 (C2’, C2``), 127.1 (C1’, 
C1``), 125.2 (C4a, C4a`), 118.6 (q, J 254.2 Hz, COCF3), 115.0 (CH-3’, CH-3``), 114.1 (C8a, C8a`), 
112.6 (CH-6’, CH-6``), 111.3 (CH-5, CH-5`), 110.2 (CH-8, CH-8`), 81.1 (ArCCAr), 56.2 (OCH3-4’, 
OCH3-4``, OCH3-5’, OCH3-5``), 56.1 (OCH3-6, OCH3-6`, OCH3-7, OCH3-7`), 55.0 (CH-1, CH-1`), 
40.2 (CH2-3, CH2-3`), 40.1 (CH2-7’, CH2-7``), 29.0 (CH2-4, CH2-4`). MS (ESI
+): m/z 901.3 (MH+, 50 
%). HRMS (ESI+): calcd for C46H47N2O10F6, 901.3135 (MH
+). Found 901.3066. 
 
3.6 General method for N-TFA deprotection. 
To a solution of the N-TFA protected amine in a mixture of CH3OH and H2O was added solid K2CO3. 
The reaction mixture was stirred at rt for 18 h. The CH3OH was evaporated and the residue was 
dissolved in EtOAc. The solution was washed with H2O (3 x) and then brine and evaporated to give a 
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yellow oil. The oil was purified by column chromatography (CH3OH : EtOAc: NH3 (4 : 6 : 0.1)) 
(unless stated otherwise) to give the free amine. 
 
 
3.6.1 (1RS and 1`RS) and (R,S) 2’,2``-(1’’,2’’-Eth-(E)-enediyl)-bis-[1,2,3,4-tetrahydro-6,7-
dimethoxy-1-(4’,5’-dimethoxyphenyl)methyl]isoquinoline (9). 
The N-TFA protected stilbene 7 (108 mg, 0.123 mmol), CH3OH (5 mL), H2O (0.6 mL) and K2CO3 (89 
mg, 0.641 mmol) were treated as described above using the general N-TFA deprotection reaction  
procedure except that the mixture was heated at 80 0C for 3 d to give a yellow oil. The oil was purified 
by column chromatography to give 9 (36 mg, 41 %) as a yellow oil. Product 9 was a 55 : 45 mixture of 
meso-9 and rac-9. Rf 0.07 (CH3OH : EtOAc (4 : 6)). 
1H NMR of meso-9:  7.07 (s, 2H, CH=CH), 6.72 
(s, 2H, H3’, H3``), 6.64 (s, 2H, H6’, H6``), 6.57 (s, 2H, H5, H5`), 6.55 (s, 2H, H8, H8`), 4.17 (dd, 2H, J 
9.0, 4.5 Hz, H1, H1`), 3.87 (s, 6H, OCH3-4’, OCH3-4``), 3.84 (s, 6H, OCH3-5’, OCH3-5``), 3.83 (s, 6H, 
OCH3-6, OCH3-6`), 3.71 (s, 6H, OCH3-7, OCH3-7`), 3.31 (dd, 2H, J 13.8, 4.5 Hz, H7’, H7``), 3.20 (dt, 
2H, J 12.0, 4.6 Hz, H3, H3`), 2.98 (dd, 2H, J 13.8, 9.0 Hz, H7’, H7``), 2.89 (dt, 2H, J 12.0, 5.4 Hz, H3, 
H3`), 2.72 (t, 4H, J 5.4 Hz, H4, H4`). 1H NMR of rac-9 (in part):  7.16 (s, 2H, CH=CH), 6.74 (s, 2H, 
H3’, H3``), 6.71 (s, 2H, H6`, H6``), 6.59 (s, 2H, H5, H5`), 6.57 (s, 2H, H8, H8`), 4.14 (dd, 2H, J 11.1, 
3.9 Hz, H1, H1`), 3.90 (s, 6H, OCH3-4’, OCH3-4``), 3.86 (s, 6H, OCH3-5’, OCH3-5``), 3.71 (s, 6H, 
OCH3-6, OCH3-6`), 3.50 (s, 6H, OCH3-7, OCH3-7`). 
13C NMR of meso-9:  148.9 (C5’, C5``), 148.3 
(C4’, C4``), 147.8 (C6, C6`), 147.2 (C7, C7`),  130.7 (C1’, C1``), 130.1 (C2’, C2``), 130.0 (C4a, C4a`), 
127.6 (C8a, C8a`), 126.8 (CH=CH), 113.9 (CH-6’, CH-6``), 112.1 (CH-3’, CH-3``), 110.0 (CH-5, CH-
5`), 109.4 (CH-8, CH-8`), 57.0 (CH-1, CH-1`), 56.3 (OCH3-5’, OCH3-5``), 56.2 (OCH3-4’, OCH3-4``, 
OCH3-6, OCH3-6`), 56.1 (OCH3-7, OCH3-7`), 40.9 (CH2-3, CH2-3`), 40.1 (CH2-7’, CH2-7``), 29.8 
(CH2-4, CH2-4`). 
13C NMR of rac-9 (in part):  148.3 (C4’, C4``), 147.4 (C7, C7`), 130.8 (C1’, C1``), 
130.3 (C2’, C2``), 129.2 (C4a, C4a`), 128.3 (CH=CH), 113.5 (CH-6’, CH-6``), 109.9 (CH-5, CH-5`), 
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56.6 (CH-1, CH-1`), 55.9 (OCH3-7, OCH3-7`), 41.1 (CH2-3, OCH3-3’), 40.0 (CH2-7’, CH2-7``), 28.6 
(CH2-4, CH2-4`). MS (ESI
+): m/z 710.92 (MH+, 20 %). HRMS (ESI+): calcd for C42H51N2O8, 711.3645 
(MH+). Found 711.3662. 
3.6.2 (1RS, 1`RS) and (R,S) 2’,2``-(1,1-Ethenediyl)-bis-[1,2,3,4-tetrahydro-6,7-dimethoxy-1-(4’,5’-
dimethoxyphenyl)methyl]isoquinoline (10). 
Compound 8 (38 mg, 0.044 mmol), CH3OH (3 mL), H2O (0.6 mL) and K2CO3 (30 mg, 0.218 mmol) 
were treated as described above using the general N-TFA deprotection reaction procedure except that 
the reaction mixture was heated at 80 0C for 5 h to give an oil. The oil was purified by column 
chromatography (CH3OH : EtOAc (4 : 6)) to give 10 (14 mg, 45 %) as a yellow oil. Product 10 was 
obtained as a diastereomeric mixture which was separated by PTLC (CH2Cl2 : EtOAc : CH3OH : NH3 
(10 : 5 : 1: 0.1)) into the major diastereomer (11 mg) and minor diastereomer (3 mg). Rf (major 
diastereomer):  0.30 (DCM : EtOAc : CH3OH : NH3 (10 : 5 : 1: 0.1)). Rf (minor diastereomer):  0.24 
(DCM : EtOAc : CH3OH : NH3 (10 : 5 : 1: 0.1)). 
1H NMR of the major diastereomer:  7.01 (s, 2H, 
H3’, H3``), 6.72 (s, 2H, H6’, H6``), 6.53 (s, 2H, H5, H5`), 5.99 (s, 2H, H8, H8`), 4.10 (dd, 2H, J 10.2, 
4.5 Hz, H1, H1`), 3.86 (s, 6H, OCH3-4’, OCH3-4``), 3.82 (s, 6H, OCH3-5’, OCH3-5``), 3.77 (s, 6H, 
OCH3-6, OCH3-6`), 3.65 (s, 6H, OCH3-7, OCH3-7`), 3.06 (dt, 2H, J 11.8, 5.1 Hz, H3, H3`), 2.92 (dd, 
2H, J 13.8, 4.5 Hz, H7’, H7``), 2.80 (ddd, 2H, J 11.8, 6.6, 4.8 Hz, H3, H3`), 2.73-7.65 (m, 4H, H4, 
H4`), 2.40 (dd, 2H, J 13.8, 10.2 Hz, H7’, H7``). 
1H NMR  of the minor diastereomer:  6.96 (s, 2H, 
H3’, H3``), 6.66 (s, 2H, H6’, H6``), 6.53 (s, 2H, H5, H5`), 6.06 (s, 2H, H8, H8`), 4.06 (dd, 2H, J 8.4, 
6.6 Hz, H1, H1`), 3.80 (s, 18H, OCH3-4’, OCH3-4``, OCH3-5’, OCH3-5``, OCH3-6, OCH3-6`), 3.62 (s, 
6H, OCH3-7, OCH3-7`), 3.10 (dt, 2H, J 12.0, 5.7 Hz, H3, H3`), 2.90 (dd, 2H, J 13.8, 6.0 Hz, H7’, 
H7``), 2.84 (dd, 2H, J 11.7, 5.4 Hz, H3, H3`), 2.68 (t, 4H, J 5.7 Hz, H4, H4`), 2.53 (dd, 2H, J 13.8, 8.4 
Hz, H7’, H7``). 13C NMR of the major diastereomer:  150.9 (C4’, C4``), 148.5 (C5’, C5``), 147.5 (C6, 
C6`), 147.2 (C7, C7`), 133.6 (C2’, C2`` and C=CH2), 130.8 (C1’, C1``), 129.2 (C4a, C4a`), 129.2 (C8a, 
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C8a`), 120.2 (ArC=CH2), 115.2 (CH-3’, CH-3``), 114.6 (CH-6’, CH-6``), 111.9 (CH-5, CH-5`), 108.7 
(CH-8, CH-8`), 56.2 (OCH3-4’, OCH3-4``), 56.0 (OCH3-5’, OCH3-5``, OCH3-6, OCH3-6`), 55.6 
(OCH3-7, OCH3-7`), 54.9 (CH-1, CH-1`), 41.4 (CH2-3, CH-3`), 40.4 (CH2-7’, CH2-7``), 29.7 (CH2-4, 
CH2-4`). 
13C NMR of the minor diastereomer:  150.7 (C4’, C4``), 148.6 (C5’, C5``), 147.6 (C6, C6`), 
147.0 (C7, C7`), 134.6 (C2’, C2`` and C=CH2), 131.0 (C1’, C1``), 129.4 (C4a, C4a`), 127.1 (C8a, 
C8a`), 119.9 (C=CH2), 114.7 (CH-3’, CH-3``), 114.3 (CH-6’, CH-6``), 112.0 (CH-5, CH-5`), 109.7 
(CH-8, CH-8`), 56.2 (OCH3-4’, OCH3-4``, OCH3-5’ OCH3-5``), 56.0 (OCH3-6, OCH3-6`), 55.9 
(OCH3-7, OCH3-7`), 55.4 (CH-1, CH-1`), 41.0 (CH2-3, CH-3`), 40.5 (CH2-7’, CH2-7``), 29.6 (CH2-4, 
CH2-4`). MS (ESI
+): m/z 711.2 (MH+, 100 %), 733.2 (M+Na+, 80 %). HRMS (ESI+): calcd for 
C42H51N2O8, 711.3645 (MH
+). Found 711.3660. 
 
3.6.3 (1RS, 1`RS) and (R,S) 2’,2``-(1’’,2’’-Ethanediyl)-bis-[1,2,3,4-tetrahydro-6,7-dimethoxy-1-
(4’,5’-dimethoxyphenyl)methyl]isoquinoline (12). 
Compound rac-11 (4 mg, 0.003 mmol), CH3OH (1 mL), H2O (0.5 mL) and K2CO3 (12 mg, 0.085 
mmol) was treated as described above using the general N-TFA deprotection reaction procedure to 
afford rac-12 (3 mg, 95 % yield) as a yellow oil without the need for further purification. Rf 0.14 
(DCM : EOAc : CH3OH : NH3 (10 : 5 : 1 : 0.1)). 
1H NMR:  6.67 (s, 2H, H3’, H3``), 6.57 (s, 2H, H5, 
H5`), 6.55 (s, 2H, H6’, H6``), 6.43 (s, 2H, H8, H8`), 4.05 (dd, 2H, J 9.3, 5.1 Hz, H1, H1`), 3.82 (s, 6H, 
OCH3-4’, OCH3-4``), 3.80 (s, 6H, OCH3-5’, OCH3-5``), 3.75 (s, 6H, OCH3-6, OCH3-6`), 3.67 (s, 6H, 
OCH3-7, OCH3-7`), 3.14 (dd, 2H, J 12.3, 6.3 Hz, H3, H3`),  3.06 (dd, 2H, J 13.8, 5.1 Hz, H7’, H7``), 
2.84 (dd, 2H, J 12.3, 6.6 Hz, H3, H3`), 2.82 (s, 4H, H1’’, H2’’), 2.75 (dd, 2H, J 13.8, 9.3 Hz, H7’, 
H7``), 2.66 (m, 4H, H4,  H4`). 
13C NMR:  147.5 (C5’, C5``), 147.4 (C4’, C4``), 147.2 (C6, C6`), 146.8 
(C7, C7`),  132.5 (C1’, C1``), 132.0 (C2’, C2``), 131.9 (C4a, C4a`), 127.0 (C8a, C8a`), 113.4 (CH-6’, 
CH-6``), 112.9 (CH-3’, CH-3``), 111.7 (CH-5, CH-5`), 109.6 (CH-8, CH-8`), 56.4 (CH-1, CH-1`), 55.8 
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(8 x OCH3), 40.7 (CH2-3, CH2-3`), 38.9 (CH2-7’, CH2-7``), 34.1 (CH2-1’’, CH2-2’’), 29.3 (CH2-4, CH2-
4`). MS (ESI+): m/z 713.3 (MH+, 100 %). HRMS (ESI+): calcd for C42H53N2O8, 713.3802 (MH
+). 
Found 713.3781. 
 
3.6.4 (1RS, 1`RS) and (1RS, 1`SR) 2’,2``-(1’’,3’’-Prop-2(E)-enediyl)-bis-[1,2,3,4-tetrahydro-6,7-
dimethoxy-1-(4’,5’dimethoxyphenyl)methyl]isoquinoline (14). 
Compound 13 (152 mg, 0.170 mmol), CH3OH (8 mL), H2O (2 mL) and K2CO3 (118 mg, 0.850 mmol) 
was treated as described above using the general N-TFA deprotection procedure to give an oil. The oil 
was purified by column chromatography to give 60 (72 mg, 58 %) as a yellow oil. Product 14 was a  60 
: 40 mixture of diastereomers. Rf 0.1 (CH3OH : EtOAc : NH3 (1 : 4 : 0.1)). 
1H NMR  of the major 
diastereomer:  6.96 (s, 1H, H3``), 6.73 (s, 2H, H3’, H5``), 6.64 (d, 1H, J 15.0 Hz, H3’’), 6.63 (s, 1H, 
H5`), 6.58 (s, 2H, H6’, H6``), 6.49 (s, 1H, H8`), 6.48 (s, 1H, H8), 6.10 (m, 1H, H2’’), 4.11 (dd, 1H, J 
8.4, 5.4 Hz, H1`),  4.03 (m, 1H, H1), 3.82 (s, 24H, 8 x OCH3), 3.51 (d, 2H, J 6.3 Hz, H1’’), 3.17 (dd, 
2H, J 13.2, 5.4 Hz, H7’, H7`), 3.12 (dd, 2H, J 12.0, 6.9 Hz, H3, H3`), 2.87 (dd, 2H, J 13.2, 8.4 Hz, H7’, 
H7``), 2.81 (dd, 2H, J 12.0, 5.1 Hz, H3, H3`), 2.70 (m, 4H, H4, H4`). 1H NMR  of the minor 
diastereomer (in part):  6.72 (s, 2H, H3’, H5``), 6.62 (s, 1H, H5`), 6.53 (s, 2H, H6’, H6``), 6.46 (s, 1H, 
H8`), 6.42 (s, 1H, H8), 6.07 (m, 1H, H2’’), 4.14 (m, 1H, H1`),  4.05 (m, 1H, H1), 3.70 (s, 24H, 8 x 
OCH3). 
13C NMR of the major diastereomer:  148.3 (C6, C6`), 148.0 (C4’, C4``), 147.8 (C5’, C5``), 
147.1 (C7, C7`), 131.1 (C1’), 131.0 (C1``), 129.8 (CH-3’’), 129.5 (C2’, C2``), 128.9 (C4a, C4a`), 128.3 
(C8a, C8a`), 127.5 (CH-2’’), 114.0 (CH-3’), 113.5 (CH-3``), 112.1 (CH-6’, CH-6``, CH-5, CH-5’), 
109.8 (CH-8), 109.3 (CH-8’), 56.2 (8 x OCH3, CH-1), 41.2 (CH2-3, CH2-3`), 39.4 (CH2-7’, CH2-7``), 
36.6 (CH2-1’’), 29.6 (CH2-4, CH2-4`). 
13C NMR of the minor diastereomer (in part):  131.0 (C1``), 
129.7 (CH-3’’), 129.5 (C2’, C2``), 128.5 (C8a, C8a`), 127.4 (CH-2’’), 113.9 (CH-3’), 36.7 (CH2-1’’), 
29.7 (CH2-4, CH2-4`). MS (ESI
+): m/z 724.88 (MH+, 100 %). HRMS (ESI+): calcd for C43H53N2O8, 
725.3802 (MH+). Found 725.3783. 
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3.6.5 (1RS, 1`RS) and (R,S) 2’,2``-(1’’,2’’-Ethynediyl)-bis-[1,2,3,4-tetrahydro-6,7-dimethoxy-1-
(4’,5’-dimethoxyphenyl)methyl]isoquinoline (19). 
Compound 18 (56 mg, 0.062 mmol), CH3OH (20 mL), H2O (2 mL) and K2CO3 (44 mg, 0.311 mmol) 
were treated as described above using the general N-TFA deprotection reaction procedure to afford an 
oil. The oil was purified by column chromatography (CH3OH : EtOAc (1 : 5)) to give 19 (34 mg, 79 % 
yield) as a brown solid.  Rf 0.06 (EtOAc). M.p. 208-210 
0C. 1H NMR:  7.20 (s, 2H, H3’, H3``), 7.00 
(s, 2H, H6’, H6``), 6.59 (s, 2H, H5, H5`), 6.35 (s, 2H, H8, H8`), 4.73 (t, 2H, J 7.5 Hz, H1, H1`), 3.84 
(s, 6H, OCH3-4’, OCH3-4``), 3.82 (s, 6H, OCH3-5’, OCH3-5``), 3.81 (s, 6H, OCH3-6, OCH3-6`), 3.65 
(s, 6H, OCH3-7, OCH3-7`), 3.51 (td, 2H, J 12.0, 4.5 Hz, H3, H3`), 3.36 (d, 4H, J 7.5 Hz, H7’, H7``), 
3.25-3.18 (m, 2H, H4, H4`), 3.13 (td, 2H, J 12.0, 4.5 Hz, H3, H3`), 3.00-2.92 (m, 2H, H4, H4`). 13C 
NMR:  149.9 (C4’, C4``), 149.5 (C5’, C5``), 149.3 (C6, C6`), 148.0 (C7, C7`), 131.1 (C2’, C2``), 
124.9 (C1’, C1``, C4a, C4a`), 124.3 (C8a, C8a`), 122.0 (CH-3’, CH-3``), 115.0 (CH-6’, CH-6``), 110.9 
(CH-5, CH-5`), 110.2 (CH-8, CH-8`), 89.9 (ArCCAr), 57.2 (OCH3-4’, OCH3-4``, OCH3-5’, OCH3-
5``), 56.5 (OCH3-6, OCH3-6`, OCH3-7, OCH3-7`), 55.3 (CH-1, CH-1`), 45.7 (CH2-3, CH2-3`), 40.2 
(CH2-7’, CH2-7``), 26.3 (CH2-4, CH2-4`). MS (ESI
+): m/z 709.1 (MH+, 5 %). HRMS (ESI+): calcd for 
C42H49N2O8, 709.3489 (MH
+). Found 709.3474. 
 
3.7 Synthesis of macrocycle 3 (Scheme 6). 
3.7.1 (RS) 1,2,3,4-Tetrahydro-6,7-dimethoxy-1-(4’,5’-dimethoxy-2’-(2’’-propenyl)-
phenyl)methylisoquinoline  (20). 
N-TFA protected amine 6 (70 mg, 0.146 mmol), K2CO3 (100 mg, 0.730 mmol), CH3OH (7 mL) and 
H2O (1 mL) were treated as described above using the general N-TFA deprotection procedure to give a 
yellow oil. The oil was purified by column chromatography (CH3OH : EtOAc (1 : 5)) to afford the 
amine 20 (50 mg, 90 %) as a yellow oil. Rf  0.21 (CH3OH : EtOAc (1 : 5)). 
1H NMR:  6.73 (s, 2H, 
H3’), 6.71 (s, 1H, H6’), 6.58 (s, 1H, H5), 6.44 (s, 1H, H8), 5.98-3.85 (m, 1H, H2’’), 5.06 (dd, 1H, J 
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9.6, 1.8 Hz, H3’’(Z)), 5.01 (dd, 1H, J 17.1, 1.8 Hz, H3’’(E)), 4.17 (dd, 1H, J 8.7, 5.7 Hz, H1), 3.85 (s, 
6H, OCH3-4’, OCH3-5’), 3.82 (s, 3H, OCH3-6), 3.73 (s, 3H, OCH3-7), 3.32 (d, 2H, J 6.0 Hz, H1’’), 
3.27 (dd, 1H, J 12.0, 6.3 Hz, H3), 3.22 (dd, 1H, J 13.8, 5.7 Hz, H7’), 2.97 (dd, 1H, J 12.0, 5.7 Hz, H3), 
2.89 (dd, 1H, J 13.8, 8.7 Hz, H7’), 2.77-2.69 (m, 2H, H4). 13C NMR:  147.9 (C4’, C5’), 147.5 (C6), 
147.2 (C7), 137.6 (CH-2’’), 130.8 (C2’), 129.9 (C1’), 129.0 (C4a), 127.0 (C8a), 115.9 (CH2-3’’), 114.0 
(CH-3’), 113.4 (CH-6’), 112.0 (CH-5), 109.8 (CH-8), 56.4 (OCH3-4’), 56.3 (OCH3-5’), 56.2 (OCH3-6), 
56.1 (OCH3-7, CH-1), 40.8 (CH2-1’’), 38.2 (CH2-7’), 37.0 (CH2-3), 29.2 (CH2-4). MS (CI
+): m/z 384 
(MH+, 60 %). HRMS (CI+): calcd for C23H30NO4, 384.2175 (MH
+). Found 384.2178. 
 
3.7.2 (RS) 1,2,3,4-Tetrahydro-6,7-dimethoxy-1(4’,5’-dimethoxy-2’-(2’’-propenyl)-
phenyl)methylisoquinoline 2-(4-oxo)butanoic acid (21). 
To a solution of the amine 20 (332 mg, 0.867 mmol) in dry CH2Cl2 (8 mL) was added triethylamine 
(0.14 mL), followed by succinic anhydride (174 mg, 1.73 mmol) under a N2 atmosphere. The reaction 
mixture was stirred at RT for 18 h. The organic layer was evaporated and the residue was redissolved 
in EtOAc. The solution was washed with 1M KHSO4 (2 x), then brine. The solution was dried (MgSO4) 
and evaporated and the crude mixture was purified by column chromatography (CH3OH : EtOAc (1 : 
5)) to give 21 (334 mg, 79 %) as a white solid. Product 21 was a 70 : 30 mixture of rotamers by 1H 
NMR analysis. Rf 0.71 (CH3OH : EtOAc (1 : 5)). M.p. 138-140 
0C. 1H NMR of the major rotamer:  
6.63 (s, 1H, H5), 6.59 (s, 1H, H3’), 6.56 (s, 1H, H6’), 5.93 (s, 1H, H8), 5.83-5.70 (m, 1H, H2’’), 5.51 
(dd, 1H, J 9.0, 5.1 Hz, H1), 4.95 (dd, 2H, J 10.2, 1.8 Hz, H3’’(Z)), 5.01 (dd, 1H, J 17.1, 1.8 Hz, 
H3’’(E)), 3.85 (s, 3H, OCH3-5’), 3.83 (s, 3H, OCH3-6), 3.75 (s, 3H, OCH3-7), 3.70-3.65 (m, 2H, H3), 
3.50 (s, 3H, OCH3-4’), 3.11 (dd, 1H, J 12.5, 5.1 Hz, H4), 3.02 (dd, 1H, J 13.5, 5.1 Hz, H7’), 3.00 (d, 
2H, J 6.3 Hz, H1’’), 2.89 (dd, 1H, J 13.5, 9.0 Hz, H7’), 2.82 (dd, 1H, J 12.5, 6.3 Hz, H4), 2.79-2.74 (m, 
4H, H2’’’, H3’’’). 1H NMR of the minor rotamer (in part):  6.69 (s, 1H, H3’), 6.63 (s, 1H, H6’), 6.49 
(s, 1H, H5), 6.44 (s, 1H, H8), 5.99-5.88 (m, 1H, H2’’), 5.11 (d, 1H, J 10.2, 1.8 Hz, H3’’(Z)), 5.00 (d, 
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1H, J 15.0, 1.8 Hz, H3’’(E)),  4.86-4.84 (m, 1H, H1), 4.73 (ddd, 1H, J 8.4, 5.7, 2.4 Hz, H3), 3.87 (s, 
3H, OCH3-5’), 3.81 (s, 3H, OCH3-7),  3.79 (s, 3H, OCH3-4’), 3.32 (d, 2H, J 6.3 Hz, H1’’), 3.23-3.18 
(m, 1H, H4), 3.12-3.08 (m, 1H, H7’), 2.92-2.89 (m, 1H, H4), 2.87-2.84 (m, 1H, H7’), 1.93-1.84 (m, 
4H, H2’’’, H3’’’). 13C NMR of the major rotamer:  175.5 (COOH), 169.8 (NCO),  146.9 (C5’), 146.5 
(C4’), 146.1 (C6), 145.9 (C7), 136.4 (CH-2’’), 130.0 (C1’), 127.2 (C2’), 126.7 (C4a), 124.6 (C8a), 
114.4 (CH2-3’’), 113.1 (CH-6’), 111.6 (CH-3’), 110.1 (CH-5), 109.8 (CH-8), 54.9 (OCH3-4’, OCH3-
5’),  54.9 (OCH3-6), 54.6 (OCH3-7), 53.0 (CH-1), 40.5 (CH2-3), 37.0 (CH2-7’), 35.3 (CH2-1’’, CH2- 4), 
27.7 (CH2-2’’’), 27.2 (CH2-3’’’). 
13C NMR of the minor rotamer (in part):  175.3 (COOH), 170.2 
(NCO), 147.3 (C5’), 147.2 (C3’), 146.6 (C6), 146.4 (C7), 136.1 (CH-2’’), 129.3 (C1’), 126.8 (C2’), 
126.4 (C4a), 125.5 (C8a), 115.0 (CH2-3’’), 113.0 (CH-6’), 112.3 (CH-3’), 110.5 (CH-5), 108.9 (CH-8), 
56.7 (CH-1), 37.8 (CH2-7’), 36.0 (CH2-1’’), 35.0 (CH2-3), 26.9 (CH2-2’’’), 26.2 (CH2-3’’’). MS (ESI
+): 
m/z 484 (MH+, 70 %). HRMS (ESI+): calcd for C27H34NO7, 484.2335 (MH
+). Found 484.2329. 
 
3.7.3 (1RS, 1`RS) and (R,S) 2’- (2’’-Propenyl)-2``-bromo-2,2’-(1’’’,4’’’-dioxo-1’’’,4’’’-butanediyl)-
bis-[1,2,3,4-tetrahydro-6,7-dimethoxy-1-(4’,5’-dimethoxyphenyl)methyl] isoquinoline (23). 
To a suspension of the amine 22 (148 mg, 0.349 mmol), the acid 21 (142 mg, 0.290 mmol), HOBT (44 
mg, 0.319 mmol) and EDCI (61 mg, 0.319 mmol) was added dry DMF (6 mL) under a N2 atmosphere. 
The reaction was stirred at RT for 3 d. The crude mixture was diluted with CH2Cl2 and washed with 
H2O (4 x) and then brine. The CH2Cl2 was evaporated to give an oil which was purified by column 
chromatography (CH3OH : EtOAc (1 : 5)) to give 23 (212 mg, 82 %) as a yellow solid. Product 23 was 
obtained as a 60 : 40 mixture  of diastereomers which were each a 70 : 30 mixture of rotamers. Rf 0.74 
(CH3OH : EtOAc (1 : 5)). M.p. 145-148 
0C. 1H NMR of the major diastereomer:  6.96 (s, 1H, H3``), 
6.57 (s, 5H, H3’, H5, H5`, H6’, H8`), 6.34 (s, 1H, H6``), 5.89 (s, 1H, H8), 5.72-5.67 (m, 1H, H2’’),  
5.47 (dd, 1H, J 9.0, 4.8 Hz, H1`), 5.18 (dd, 1H, J 9.0, 4.8 Hz, H1), 4.96-4.86 (m, 2H, H3’’), 3.84 (s, 
18H, 6 x OCH3), 3.84-3.76 (m, 4H, H3, H3`), 3.72 (s, 6H, OCH3-4’, OCH3-4``), 3.27-3.20 (m, 1H, 
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H4`), 3.09-3.05 (m, 1H, H4), 3.03-2.98 (m, 2H, H1’’), 2.82-2.76 (m, 4H, H7’, H7``), 2.68-2.60 (m, 6H, 
H4`, H4, H2’’’, H3’’’). 1H NMR of the minor diastereomer (in part):  7.03 (s, 1H, H3``), 6.59 (s, 5H, 
H3’, H5, H5`, H6’, H8`), 6.20 (s, 1H, H6``), 5.84 (s, 1H, H8), 5.66-5.60 (m, 1H, H2’’), 5.42 (dd, 1H, J 
9.9, 4.2 Hz, H1`), 5.13 (dd, 1H, J 9.9, 4.2 Hz, H1), 5.05-5.02 (m, 2H, H3’’), 2.30-2.26 (m, 4H, H2’’’, 
H3’’’). 1H NMR of the minor rotamer of both diasteromers (in part), (note-*- represents the rotamer of 
the minor diastereomer):  7.02 (s, 1H, H3``), 6.95 (s, 1H, H3``*), 6.54 (s, 5H, H3’, H5, H5`, H6’, 
H8`), 6.52 (s, 5H, H3’, H5, H5`, H6’, H8`*), 5.88 (s, 1H, H8), 5.86 (s, 1H, H8*), 4.76-4.68 (m, 2H, H3, 
H3`), 2.58-2.54 (m, 2H, H3’’’), 2.32-2.28 (m, 2H, H2’’’). 13C NMR of the major diastereomer:  171.1 
(2 x NCO), 148.3 (C5’, C5``, C4’, C4``), 148.1 (C6, C6`), 147.5 (C7, C7`), 137.7 (CH-2’’), 132.3 (C1’, 
C1``), 132.2 (C2’, C2``), 128.8 (C4a, C4a`), 128.6 (C8a, C8a`), 115.7 (CH-6’, CH6``), 115.3 (CH2-3’’), 
111.6 (CH-3’, CH-3``), 111.1 (CH-5, CH-5`), 110.8 (CH-8, CH-8`), 56.1 (8 x OCH3), 53.5 (CH-1, CH-
1``), 42.6 (CH2-3`), 41.0 (CH2-7``), 38.4 (CH2-3), 36.6 (CH2-7’), 36.0 (CH2-1’’), 29.1 (CH2-3’’’, CH2-
2’’’), 28.7 (CH2-4`), 28.1 (CH2-4). 
13C NMR of the minor diastereomer (in part):  131.2 (C1’, C1`), 
129.8 (C2’, C2`), 128.3 (C4a, C4a`), 126.8 (C8a, C8a`), 111.3 (CH-3’, CH-3``), 111.0 (CH-5, CH5`), 
110.3 (CH-8, CH8`), 35.7 (CH2-1’’). MS (ESI
+): m/z 886.79 (MH+, 10 %). HRMS (ESI+): calcd for 
C47H56N2O10Br, 887.3118 (MH
+). Found 887.3137. 
 
3.7.4 (1RS, 1`RS) and (R,S) (E) 1,10-(1,2)-Di-(1,2,3,4-tetrahydro-6,7-dimethoxyisoquinolina)-3,8-
(1,2)-di-(3,4-dimethoxy)benzenacyclo-(11,14-dioxo)-propadeca-4-phene (3). 
To a mixture of  23 (71 mg, 0.080 mmol), Pd(OAc)2 (2 mg, 0.008 mmol) and PPh3 (4 mg, 0.016 mmol) 
in a thick walled tube was added dry CH3CN (2 mL) under a N2 atmosphere. Triethylamine (25 mg, 
0.240 mmol, 0.04 mL) was added and  the reaction was bubbled with argon for 5 min prior to sealing 
the tube. The solution mixture was stirred and heated at 110 0C for 24 h. The solution was diluted with 
CH2Cl2, washed with H2O, and then brine. The CH2Cl2 layer was evaporated to give an oil which was 
purified by column chromatography (CH3OH : EtOAc (1 : 9))  to give 3 (12 mg, 15 %) as a yellow oil. 
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Rf 0.61 (CH3OH : EtOAc (1 : 9)).  
1H NMR:  6.93 (d, 1H, J 15.3 Hz, H3’’), 6.86 (s, 1H, H5`), 6.81 (s, 
1H, H5), 6.64 (s, 1H, H3``), 6.59 (s, 1H, H3’), 6.49 (s, 1H, H6``), 6.02 (s, 1H, H6’), 5.95-5.88 (m, 1H, 
H2’’), 5.90 (s, 1H, H8`), 5.88 (s, 1H, H8), 5.66 (dd, 1H, J 9.0, 3.0 Hz, H1`), 5.55 (dd, 1H, J 9.0, 3.0 Hz, 
H1),  4.40 (dd, 1H, J 13.5, 9.6 Hz, H3`), 4.00-3.85 (m, 1H, H3), 3.88 (s, 3H, OCH3-5``), 3.85 (s, 6H, 
OCH3-5’, OCH3-7), 3.83 (s, 3H, OCH3-7`), 3.73 (s, 3H, OCH3-6), 3.57 (s, 3H, OCH3-6`), 3.49 (s, 6H, 
OCH3-4’, OCH3-4``), 3.70-3.64 (m, 1H, H3), 3.45-3.40 (m, 1H, H3`), 3.41-3.36 (m, 2H, H3’’’),  3.34 
(d, 2H, J 7.5 Hz, H1’’), 3.23-3.18 (m, 2H, H7``, H7``), 3.04 (dd, 1H, J 13.2, 3.0  Hz, H7’), 2.99 (d, 1H, 
J 13.2, 9.0 Hz, H7’), 2.84-2.67 (m, 2H, H4, H4’), 2.43-2.38 (m, 1H, H2’’’), 2.26-2.22 (m, 1H, H2’’’).   
13C NMR:  172.1 (CO), 171.2 (CO), 147.9 (C6`), 147.7 (C6), 147.5 (C4’, C4``), 147.3 (C5``), 147.0 
(C5’), 146.6 (C7`), 146.2 (C7), 132.1 (CH-3’’), 132.4 (C1``), 130.1 (C1’), 129.1 (C2``),  128.8 (C2’), 
128.7 (CH-2’’), 128.1 (C4a`), 126.0 (C4a), 126.5 (C8a, C8a`), 115.7 (CH-6``), 113.7 (CH-6’), 113.1 
(CH-3``), 111.9 (CH-3’), 111.1 (CH-5`), 110.9 (CH-5), 110.8 (CH-8`), 109.5 (CH-8), 51.7 (8 x OCH3), 
54.8 (CH-1`), 54.3 (CH-1), 41.7 (CH2-3`), 41.1 (CH2-3), 40.2 (CH2-7``), 39.0 (CH2-7’), 36.6 (CH2-1’’), 
29.7 (CH2-3’’’), 28.6 (CH2-2’’’), 28.3 (CH2-4`), 28.0 (CH2-4). MS (ESI
+): m/z 807.09 (MH+, 5 %), m/z 
844.86 (M+K+, 20 %). HRMS (ESI+): calcd for C47H55N2O10, 807.3857 (MH
+). Found 807.3842. 
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